We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

61 hedge funds and large institutions have $34.8M invested in Matinas BioPharma in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.48% → 0.46% (-0.02%)

5% less capital invested

Capital invested by funds: $36.7M → $34.8M (-$1.91M)

6% less funds holding

Funds holding: 65 → 61 (-4)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
61
Holders Change
-4
Holders Change %
-6.15%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$479K
2
SIG
Sargent Investment Group
Maryland
+$364K
3
Two Sigma Investments
Two Sigma Investments
New York
+$148K
4
WG
Winton Group
United Kingdom
+$109K
5
BCM
Bridgeway Capital Management
Texas
+$104K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$1.62M
2
Millennium Management
Millennium Management
New York
-$279K
3
Renaissance Technologies
Renaissance Technologies
New York
-$206K
4
Jane Street
Jane Street
New York
-$199K
5
Wells Fargo
Wells Fargo
California
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Boxer Capital
California
$8.79M – – –
VC
2
Vivo Capital
California
$8.64M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.84M – – –
BlackRock
4
BlackRock
New York
$1.71M +$26K +653 +1%
Two Sigma Investments
5
Two Sigma Investments
New York
$1.13M +$148K +3,731 +15%
Victory Capital Management
6
Victory Capital Management
Texas
$907K -$29.5K -743 -3%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$826K – – –
Two Sigma Advisers
8
Two Sigma Advisers
New York
$764K +$479K +12,036 +152%
BCM
9
Bridgeway Capital Management
Texas
$648K +$104K +2,612 +18%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$608K – – –
SIG
11
Sargent Investment Group
Maryland
$592K +$364K +9,159 +146%
RJFSA
12
Raymond James Financial Services Advisors
Florida
$548K +$10.3K +260 +2%
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
$460K – – –
SCA
14
STALEY CAPITAL ADVISERS
Pennsylvania
$460K – – –
DA
15
DCF Advisers
Connecticut
$423K -$9.54K -240 -2%
Wells Fargo
16
Wells Fargo
California
$286K -$153K -3,852 -34%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$270K – – –
WIC
18
Water Island Capital
New York
$268K -$119K -3,000 -30%
Northern Trust
19
Northern Trust
Illinois
$215K -$994 -25 -0.4%
WG
20
Winton Group
United Kingdom
$182K +$109K +2,742 +136%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$153K – – –
PTP
22
Platform Technology Partners
New York
$130K +$19.2K +483 +17%
UBS Group
23
UBS Group
Switzerland
$110K +$26.1K +657 +30%
PAG
24
Private Advisor Group
New Jersey
$106K – – –
State Street
25
State Street
Massachusetts
$97K – – –
1
2 3

MTNB Hedge Fund Activity: Q3 2020 in Review

61 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q3 2020, worth a combined $34.8M — down 5.2% from $36.7M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MTNB and 7 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 13 added.

The largest buyer was Two Sigma Advisers, adding an estimated $479K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1.62M sold.

  • 61 institutional investors held Matinas BioPharma (MTNB) as of Q3 2020, down from 65 in Q2 2020.
  • Funds reported $34.8M of Matinas BioPharma stock for Q3 2020, down 5.2% quarter-over-quarter.
  • 7 funds opened new Matinas BioPharma positions in Q3 2020 and 11 closed out, a net change of -4 holders.
  • The largest Matinas BioPharma buyer in Q3 2020 was Two Sigma Advisers, an estimated $479K added.
  • The largest Matinas BioPharma seller in Q3 2020 was Baker Bros. Advisors, an estimated $1.62M sold.

Based on aggregated 13F filings for Q3 2020.